Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
Clinical trial NCT05306301 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05306301
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-05
- Primary completion
- 2026-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.